Apteeus has started a tailor-made research program for the association Les Petits Mec P2. Less than 18 months after the first exchanges with the association and opinion leaders in the field, several thousand molecules for human use were tested on the cells of Sacha, a child suffering from MeCP2 gene duplication syndrome. We have identified..
Rare Disease 360°, Collaborative Strategies to leave no-one behind Proud to present the high potential of APTEEUS Protein Re-expression Therapy, Isabelle will attend the European Conference on Rare Diseases and Orphan Products in Vienne. SHe will also expose the innovative way APTEEUS and Les Petits MeCP2 association are collaborating.
Camille, Isabelle, Loïc, Simon, Benoit and Terence wish you all the best for 2018.
All the team wish you the best for this new year.
The first edition of Hibster is 120 brains in turmoil, 48h of thinking for unlimited creativity. One team will work on individualized medicine proposed by APTEEUS. Eager to see the result!